Literature DB >> 35044794

B Cell Function in the Tumor Microenvironment.

Stephanie M Downs-Canner1,2, Jeremy Meier3, Benjamin G Vincent3,4,5, Jonathan S Serody3,5.   

Abstract

The tumor microenvironment (TME) is a heterogeneous, complex organization composed of tumor, stroma, and endothelial cells that is characterized by cross talk between tumor and innate and adaptive immune cells. Over the last decade, it has become increasingly clear that the immune cells in the TME play a critical role in controlling or promoting tumor growth. The function of T lymphocytes in this process has been well characterized. On the other hand, the function of B lymphocytes is less clear, although recent data from our group and others have strongly indicated a critical role for B cells in antitumor immunity. There are, however, a multitude of populations of B cells found within the TME, ranging from naive B cells all the way to terminally differentiated plasma cells and memory B cells. Here, we characterize the role of B cells in the TME in both animal models and patients, with an emphasis on dissecting how B cell heterogeneity contributes to the immune response to cancer.

Entities:  

Keywords:  B cell; Breg; antibody; immunogenomics; tertiary lymphoid structure; tumor microenvironment

Mesh:

Year:  2022        PMID: 35044794     DOI: 10.1146/annurev-immunol-101220-015603

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  5 in total

Review 1.  Cancer vaccines: Building a bridge over troubled waters.

Authors:  MacLean C Sellars; Catherine J Wu; Edward F Fritsch
Journal:  Cell       Date:  2022-07-13       Impact factor: 66.850

2.  Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer.

Authors:  Kai Hong; Yingjue Zhang; Lingli Yao; Jiabo Zhang; Xianneng Sheng; Lihua Song; Yu Guo; Yangyang Guo
Journal:  Front Cell Dev Biol       Date:  2022-08-19

Review 3.  Immune cell-antibody interactions in health and disease.

Authors:  Sophia N Karagiannis; James N Arnold
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

Review 4.  The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment.

Authors:  Xintian Chen; Menghan Cao; Pengfei Wang; Sufang Chu; Minle Li; Pingfu Hou; Junnian Zheng; Zhongwei Li; Jin Bai
Journal:  Front Immunol       Date:  2022-09-09       Impact factor: 8.786

5.  Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy.

Authors:  Zhengjun Lin; Yanlin Wu; XunGang Xiao; Xianghong Zhang; Jia Wan; Tao Zheng; Hongxuan Chen; Tang Liu; Xianzhe Tang
Journal:  Front Genet       Date:  2022-09-09       Impact factor: 4.772

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.